Keyphrases
Human Induced Pluripotent Stem Cell-derived Cardiomyocytes (hiPSC-CMs)
100%
Cardiomyocytes
83%
Multi-walled Carbon Nanotubes (MWCNTs)
76%
Degradation Rate
64%
Stem Cells
57%
Porosity
51%
Functional Groups
51%
Engineered Heart Tissue
46%
Contractility
46%
Fourier Transform Infrared Spectroscopy (FT-IR)
44%
Multicentre Evaluation
38%
Automated Platform
38%
Cardiac Patch
38%
Hypomobility
38%
Human Pluripotent Stem Cells (hPSCs)
38%
Hypertrophic Cardiomyopathy
38%
CRISPR-Cas9 Editing
38%
Energy Depletion
38%
Drug Discovery
38%
Biomedicine
38%
Graphite
38%
Hyaluronic Acid
38%
Graphene Oxide
38%
Chitosan
38%
Induced Pluripotent Stem Cells (iPSCs)
38%
Physical Characterization
38%
Physicochemical Characteristics
38%
Tissue-engineered Constructs
38%
Oxide Materials
38%
Cell Tissue Culture
38%
Tissue Engineering Applications
38%
Putative Drug Targets
38%
Collagen Alginate
38%
Drug-induced
38%
Chemical Characterization
38%
Zinc Oxide
38%
Bioreactor System
38%
Cardiomyoplasty
38%
Evidence-based
38%
Scaffold for Tissue Engineering
38%
Biocompatibility
38%
Bioreactor
38%
Rutile
38%
Reduced Graphene Oxide
38%
Platinum Coating
38%
Polyvinyl Alcohol
38%
Myocardial Infarction
38%
Polyetheretherketone Implant
38%
Hydroxyapatite Scaffold
38%
Improved Biocompatibility
38%